The beginning of 2026 marked a definitive turning point in China’s digital regulatory landscape. more…
China’s new Provisions on the Protection of Trade Secrets, more…
On 1 September 2026, the revised Good Clinical Practice for Drug Trials (the “2026 GCP”) took effect, replacing the previous more…
As foreign-invested more…
China's auto exports hit 7.098 million units in 2025, up 21.1% year-on-year — with new energy vehicles more…
China's cross-border data transfer regime is no longer a paper framework. The three more…
Doing business in or with China requires staying informed about a rapidly evolving legal and regulatory landscape. New more…
On 27 December 2025, China passed the revised Foreign Trade Law of the People’s Republic of China more…
Executive SummaryIn 2026, foreign-invested enterprises should prioritize several action items: more…
China’s NEV market more…
Cross border transfer of personal information is increasingly a more…
Together with Yongmei Evers-Cai, Jan Holthuis authored a report more…
